Diffuse large B-cell lymphoma (DLBCL) is a type of non-Hodgkin lymphoma characterized by the rapid proliferation of large B-cells. It is the most common subtype of lymphoma and can arise in various sites throughout the body. Accurate coding with ICD-10 Code C83.30 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources are allocated effectively.
What is ICD-10 Code C83.30 for Diffuse large B-cell lymphoma, unspecified site?
ICD-10 Code C83.30 represents Diffuse large B-cell lymphoma, unspecified site, indicating a diagnosis of this aggressive lymphoma without specifying the location of the tumor. This code is used when the lymphoma is confirmed but the exact site of involvement is not documented. It is crucial for clinical documentation and billing to ensure accurate representation of the patient's condition.
ICD-10 Code C83.30 – Clinical Definition and Explanation of Diffuse large B-cell lymphoma, unspecified site
Diffuse large B-cell lymphoma is a hematological malignancy that arises from B-lymphocytes and is characterized by large, atypical cells. The etiology is often multifactorial, including genetic mutations and environmental factors. Prompt diagnosis and treatment are critical due to the aggressive nature of the disease.
Key Clinical Features:
- Rapidly enlarging lymph nodes, often in the neck, axilla, or abdomen.
- B symptoms such as fever, night sweats, and weight loss.
- Cytopenias due to bone marrow involvement.
- Elevated lactate dehydrogenase (LDH) levels indicating tumor burden.
ICD-10 Code C83.30 for Diffuse large B-cell lymphoma, unspecified site – SOAP Notes & Clinical Use
ICD-10 Code C83.30 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a vital role in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and facilitating appropriate management strategies.
What Does ICD-10 Code C83.30 for Diffuse large B-cell lymphoma, unspecified site Mean in SOAP Notes?
In SOAP notes, ICD-10 Code C83.30 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of diffuse large B-cell lymphoma. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Treatment Options for ICD-10 Code C83.30 – Diffuse large B-cell lymphoma, unspecified site
Diffuse large B-cell lymphoma requires urgent medical intervention, often necessitating hospitalization for treatment initiation.
Antibiotic Therapy:
- Not applicable as DLBCL is not an infectious disease; treatment typically involves chemotherapy.
- R-CHOP regimen is commonly used, consisting of Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
Supportive Care:
- Management of symptoms such as pain and nausea.
- Blood transfusions for anemia or thrombocytopenia.
- Antiemetics for chemotherapy-induced nausea.
Infection Control:
- Strict hand hygiene to prevent infections during immunosuppression.
- Prophylactic antibiotics may be considered in high-risk patients.
How to Document Symptoms of Diffuse large B-cell lymphoma, unspecified site (ICD-10 C83.30) in SOAP Notes
Subjective:
- Patient reports unexplained weight loss of 15 pounds over the past month.
- Complains of persistent night sweats and fatigue.
- Noticed a painless swelling in the neck region.
- Denies any recent infections or travel history.
Objective:
- Physical examination reveals enlarged cervical lymph nodes.
- Laboratory tests show elevated LDH levels.
- CT scan indicates lymphadenopathy in multiple regions.
- Bone marrow biopsy confirms DLBCL.
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Diffuse large B-cell lymphoma, unspecified site (ICD-10 Code C83.30)
Assessment:
- Diagnosis of Diffuse large B-cell lymphoma, unspecified site, confirmed.
- ICD-10 Code C83.30 applied.
- Consideration of potential contributing factors such as immunosuppression.
Plan:
- Initiate R-CHOP chemotherapy regimen.
- Schedule follow-up appointments for monitoring response to treatment.
- Educate patient on potential side effects and signs of infection.
- Arrange for supportive care services as needed.
Treatment & Plan Section for ICD-10 Code C83.30 – Diffuse large B-cell lymphoma, unspecified site
- First-line treatment includes R-CHOP chemotherapy regimen.
- Consider radiation therapy for localized disease after chemotherapy.
- Monitor for treatment response through imaging and laboratory tests.
- Provide patient education on managing side effects and maintaining health.
Using ICD-10 Code C83.30 for Diffuse large B-cell lymphoma, unspecified site in Billing & SOAP Note Compliance
- Ensure accurate documentation of symptoms and clinical findings in SOAP notes.
- Use C83.30 when the site of lymphoma is unspecified to support billing.
- Align treatment plans with clinical guidelines to justify coding.
- Include relevant CPT codes that correspond to the services provided.
Related ICD-10 Codes Often Used with Diffuse large B-cell lymphoma, unspecified site
ICD-10 Code C83.30 in Medical Billing and Insurance for Diffuse large B-cell lymphoma, unspecified site
ICD-10 Code C83.30 is critical in medical billing, particularly in hospital and emergency settings.
Billing Notes:
- Document all relevant clinical findings and treatment plans to support the use of C83.30.
- Ensure that the code is used in conjunction with appropriate CPT codes for billing.
- Maintain clear records of patient interactions and treatment responses.
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 36415 | Collection of venous blood by venipuncture. |
| 85025 | Complete blood count with automated differential. |
Frequently Asked Questions
Common Questions About Using ICD-10 Code C83.30 for Diffuse large B-cell lymphoma, unspecified site
What are the common symptoms of diffuse large B-cell lymphoma?
Common symptoms include swollen lymph nodes, unexplained weight loss, fever, night sweats, and fatigue. Patients may also experience pain or discomfort in affected areas.
How is diffuse large B-cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of lymph nodes or affected tissue to confirm the presence of large B-cells.
What is the treatment for diffuse large B-cell lymphoma?
Treatment usually involves chemotherapy, often with the R-CHOP regimen, and may include radiation therapy depending on the stage and location of the disease.
Is diffuse large B-cell lymphoma curable?
Diffuse large B-cell lymphoma is considered aggressive but potentially curable, especially when diagnosed early and treated promptly with appropriate therapies.
